ZILEUTON

ZILEUTON was reported 651 times

ZILEUTON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOOTH ANKYLOSIS 1 0.0769
1 CEREBROSPINAL FLUID DRAINAGE 1 0.0385
2 MONONUCLEOSIS HETEROPHILE TEST POSITIVE 1 0.0185
3 OCCUPATIONAL ASTHMA 1 0.0172
4 ANALGESIC ASTHMA SYNDROME 1 0.0154
5 PROPHYLAXIS 1 0.0122
6 SPOUSAL ABUSE 1 0.0120
7 INFECTIVE THROMBOSIS 1 0.0112
8 BACTERIA URINE 1 0.0104
9 LYMPHATIC FISTULA 1 0.0100
10 BRONCHOSPASM PARADOXICAL 3 0.0100
11 DURAL ARTERIOVENOUS FISTULA 1 0.0095
12 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
13 LIVER FUNCTION TEST 1 0.0085
14 CORNEAL DEFECT 1 0.0076
15 VASOMOTOR RHINITIS 1 0.0075
16 NASAL POLYPECTOMY 1 0.0063
17 EYE DEGENERATIVE DISORDER 1 0.0060
18 LARYNGEAL INJURY 1 0.0058
19 SCAR EXCISION 1 0.0056
20 BIOPSY LUNG 2 0.0054
21 FAILED INDUCTION OF LABOUR 1 0.0052
22 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 3 0.0049
23 INCREASED NEED FOR SLEEP 1 0.0043
24 STATUS ASTHMATICUS 2 0.0042
25 LOWER RESPIRATORY TRACT INFLAMMATION 1 0.0037
26 ORTHOSIS USER 1 0.0036
27 ASBESTOSIS 1 0.0035
28 PREMATURE AGEING 1 0.0034
29 TYMPANIC MEMBRANE DISORDER 1 0.0031
30 COUNTERFEIT DRUG ADMINISTERED 1 0.0029
31 ANION GAP DECREASED 1 0.0029
32 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
33 NSAID EXACERBATED RESPIRATORY DISEASE 1 0.0026
34 MOUTH BREATHING 1 0.0023
35 EYELID INFECTION 1 0.0023
36 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
37 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
38 CEREBRAL HYPOPERFUSION 1 0.0021
39 RESPIRATORY TRACT INFLAMMATION 1 0.0021
40 MASTOCYTOSIS 1 0.0021
41 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
42 SEPSIS SYNDROME 1 0.0020
43 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
44 SINUSITIS BACTERIAL 2 0.0019
45 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
46 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
47 HALO VISION 2 0.0018
48 URINE COLOUR ABNORMAL 1 0.0018
49 MEDICAL DEVICE SITE INFECTION 1 0.0016
50 INHALATION THERAPY 1 0.0016
51 RECTAL FISSURE 1 0.0016
52 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
53 MUCOSAL DISCOLOURATION 1 0.0016
54 ANOXIC ENCEPHALOPATHY 1 0.0016
55 ABDOMINAL OPERATION 2 0.0015
56 ORAL MUCOSAL DISCOLOURATION 1 0.0015
57 ARTHROSCOPY 1 0.0015
58 TRYPTASE INCREASED 1 0.0014
59 SMALL FIBRE NEUROPATHY 1 0.0014
60 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
61 VEIN COLLAPSE 1 0.0013
62 ELECTROMECHANICAL DISSOCIATION 1 0.0013
63 VASCULAR ACCESS COMPLICATION 1 0.0012
64 INFECTED BITE 1 0.0012
65 APTYALISM 1 0.0012
66 MYCOTIC ALLERGY 1 0.0012
67 CLEFT LIP 1 0.0011
68 JAW OPERATION 1 0.0011
69 OROPHARYNGEAL CANDIDIASIS 1 0.0011
70 PSYCHOGENIC SEIZURE 1 0.0011
71 CARDIAC ANEURYSM 1 0.0010
72 ATYPICAL PNEUMONIA 3 0.0010
73 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
74 PHARYNGEAL ERYTHEMA 2 0.0009
75 SUPERFICIAL INJURY OF EYE 1 0.0009
76 POST PROCEDURAL SWELLING 1 0.0009
77 RHINITIS ALLERGIC 4 0.0009
78 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
79 EYELID SKIN DRYNESS 1 0.0008
80 OTITIS EXTERNA 1 0.0008
81 INFUSION SITE WARMTH 1 0.0008
82 PARANASAL SINUS DISCOMFORT 3 0.0008
83 SEROMA 1 0.0008
84 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
85 STENOTROPHOMONAS INFECTION 1 0.0007
86 INFUSION SITE RASH 1 0.0007
87 MAST CELL ACTIVATION SYNDROME 1 0.0007
88 CONJUNCTIVITIS ALLERGIC 1 0.0007
89 ASTHMA 76 0.0007
90 SUPERINFECTION 1 0.0007
91 HYPOAESTHESIA FACIAL 1 0.0007
92 HYPOSMIA 1 0.0007
93 MEAN CELL VOLUME DECREASED 1 0.0006
94 EYE ALLERGY 1 0.0006
95 INFUSION SITE SWELLING 4 0.0006
96 TOTAL LUNG CAPACITY DECREASED 1 0.0006
97 PHARYNGEAL SWELLING 6 0.0006
98 TROPONIN I INCREASED 1 0.0006
99 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
100 SENSITIVITY OF TEETH 1 0.0006
101 OTORRHOEA 1 0.0006
102 ROTATOR CUFF REPAIR 1 0.0006
103 JOINT ARTHROPLASTY 1 0.0006
104 NASAL OEDEMA 1 0.0006
105 CEREBRAL VENOUS THROMBOSIS 1 0.0006
106 OESOPHAGEAL SPASM 1 0.0005
107 LOBAR PNEUMONIA 1 0.0005
108 CHRONIC SINUSITIS 2 0.0005
109 NARCOLEPSY 1 0.0005
110 MOTION SICKNESS 1 0.0005
111 TRAUMATIC LUNG INJURY 1 0.0005
112 RHINITIS 4 0.0005
113 HOMICIDAL IDEATION 2 0.0005
114 IMPAIRED QUALITY OF LIFE 7 0.0005
115 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
116 DILATATION VENTRICULAR 1 0.0005
117 INFUSION SITE ERYTHEMA 4 0.0005
118 HEPATIC NEOPLASM MALIGNANT 1 0.0005
119 REACTION TO DRUG EXCIPIENTS 1 0.0005
120 DYSPHEMIA 2 0.0005
121 PHARYNGEAL OEDEMA 7 0.0005
122 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
123 INFECTIOUS MONONUCLEOSIS 1 0.0004
124 HAEMATOCRIT INCREASED 1 0.0004
125 HAEMOGLOBIN INCREASED 2 0.0004
126 ORAL PRURITUS 1 0.0004
127 ARTHRITIS INFECTIVE 2 0.0004
128 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
129 OXYGEN CONSUMPTION INCREASED 1 0.0004
130 GASTROINTESTINAL OBSTRUCTION 1 0.0004
131 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
132 ORAL INTAKE REDUCED 1 0.0004
133 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
134 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
135 CARTILAGE INJURY 1 0.0004
136 ANAPHYLACTIC REACTION 22 0.0004
137 OSTEITIS 1 0.0004
138 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
139 NOCARDIOSIS 1 0.0004
140 MENOPAUSE 1 0.0004
141 WHEEZING 23 0.0004
142 CATHETER SITE PAIN 1 0.0004
143 MALABSORPTION 2 0.0004
144 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
145 EXFOLIATIVE RASH 1 0.0004
146 ANIMAL BITE 1 0.0004
147 YAWNING 1 0.0004
148 LARYNGOSPASM 1 0.0004
149 WRONG PATIENT RECEIVED MEDICATION 1 0.0004
150 ORAL FUNGAL INFECTION 1 0.0004
151 RED BLOOD CELL COUNT INCREASED 1 0.0004
152 PLEURITIC PAIN 1 0.0004
153 CHOLECYSTITIS INFECTIVE 1 0.0004
154 SERUM SICKNESS 1 0.0004
155 DRUG TOLERANCE DECREASED 1 0.0004
156 PSYCHOMOTOR RETARDATION 1 0.0004
157 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
158 BREAST CANCER STAGE IV 1 0.0004
159 BRONCHOSPASM 5 0.0004
160 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
161 STRABISMUS 1 0.0003
162 PLEURISY 2 0.0003
163 FACIAL PAIN 3 0.0003
164 GANGRENE 2 0.0003
165 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
166 EYELIDS PRURITUS 1 0.0003
167 EOSINOPHILIC PNEUMONIA 1 0.0003
168 INFUSION SITE PRURITUS 1 0.0003
169 EXPOSURE TO TOXIC AGENT 1 0.0003
170 VENTRICULAR HYPOKINESIA 1 0.0003
171 OEDEMA MOUTH 1 0.0003
172 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
173 WOUND DEHISCENCE 1 0.0003
174 THROAT TIGHTNESS 8 0.0003
175 CLOSTRIDIAL INFECTION 1 0.0003
176 DEPRESSION SUICIDAL 1 0.0003
177 LARGE INTESTINE PERFORATION 2 0.0003
178 AORTIC STENOSIS 1 0.0003
179 TYPE I HYPERSENSITIVITY 1 0.0003
180 HEREDITARY ANGIOEDEMA 3 0.0003
181 FACIAL BONES FRACTURE 1 0.0003
182 MONOCYTE COUNT INCREASED 1 0.0003
183 CAROTID ARTERY OCCLUSION 1 0.0003
184 FREEZING PHENOMENON 1 0.0003
185 HYPERACUSIS 1 0.0003
186 BONE DENSITY ABNORMAL 1 0.0003
187 HEPATIC NECROSIS 1 0.0003
188 CATHETER SITE INFECTION 1 0.0003
189 TONGUE OEDEMA 1 0.0003
190 PARANASAL SINUS HYPERSECRETION 1 0.0003
191 SLEEP APNOEA SYNDROME 5 0.0003
192 THYROID MASS 1 0.0003
193 SENSATION OF HEAVINESS 1 0.0003
194 MULTIPLE ALLERGIES 2 0.0003
195 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
196 VENOUS THROMBOSIS 1 0.0003
197 NASAL DISCOMFORT 2 0.0003
198 SKIN PAPILLOMA 1 0.0002
199 CANDIDIASIS 1 0.0002
200 BACK DISORDER 4 0.0002
201 DEMYELINATION 1 0.0002
202 CARDIOMEGALY 3 0.0002
203 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
204 CONGESTIVE CARDIOMYOPATHY 1 0.0002
205 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
206 BUNDLE BRANCH BLOCK LEFT 1 0.0002
207 ABSCESS LIMB 1 0.0002
208 SINUSITIS 24 0.0002
209 LUNG NEOPLASM 1 0.0002
210 TENSION HEADACHE 1 0.0002
211 HORDEOLUM 1 0.0002
212 ONYCHOMYCOSIS 1 0.0002
213 ORAL CANDIDIASIS 3 0.0002
214 PARONYCHIA 1 0.0002
215 HAEMORRHAGIC ANAEMIA 1 0.0002
216 CATHETERISATION CARDIAC 1 0.0002
217 EAR INFECTION 6 0.0002
218 BRAIN NEOPLASM MALIGNANT 1 0.0002
219 MENINGITIS ASEPTIC 1 0.0002
220 ABDOMINAL HERNIA 1 0.0002
221 EXOSTOSIS 2 0.0002
222 INCREASED TENDENCY TO BRUISE 2 0.0002
223 NERVE COMPRESSION 2 0.0002
224 MULTIPLE MYELOMA 1 0.0002
225 FEELING OF DESPAIR 1 0.0002
226 PERFORMANCE STATUS DECREASED 1 0.0002
227 BLOOD SODIUM DECREASED 4 0.0002
228 SEASONAL ALLERGY 3 0.0002
229 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
230 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
231 LIMB OPERATION 1 0.0002
232 HUMERUS FRACTURE 1 0.0002
233 INCORRECT DOSAGE ADMINISTERED 1 0.0002
234 NASAL POLYPS 1 0.0002
235 CARDIOMYOPATHY 3 0.0002
236 BREATH SOUNDS ABNORMAL 1 0.0002
237 ORGANISING PNEUMONIA 1 0.0002
238 HAEMATOCRIT DECREASED 4 0.0002
239 IMMUNODEFICIENCY 3 0.0002
240 CORONARY ARTERIAL STENT INSERTION 1 0.0002
241 EAR DISCOMFORT 2 0.0002
242 INCREASED UPPER AIRWAY SECRETION 1 0.0002
243 TRISMUS 1 0.0002
244 EYE DISCHARGE 2 0.0002
245 SCRATCH 2 0.0002
246 SERUM FERRITIN INCREASED 1 0.0002
247 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
248 NYSTAGMUS 1 0.0002
249 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
250 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
251 CHEST DISCOMFORT 19 0.0002
252 PRODUCT RESIDUE PRESENT 1 0.0002
253 ERYTHEMA OF EYELID 1 0.0002
254 SKIN LACERATION 2 0.0002
255 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
256 JAW DISORDER 1 0.0002
257 HYPERKERATOSIS 1 0.0002
258 RESPIRATORY DISTRESS 5 0.0002
259 STREPTOCOCCAL INFECTION 1 0.0002
260 ANGIOPATHY 1 0.0002
261 OCULAR DISCOMFORT 2 0.0002
262 PANCREATITIS ACUTE 4 0.0002
263 SKIN TOXICITY 1 0.0002
264 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
265 CHOLECYSTECTOMY 2 0.0002
266 SKIN ATROPHY 1 0.0002
267 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
268 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
269 RALES 1 0.0002
270 VASCULITIS 2 0.0002
271 DECREASED INTEREST 1 0.0002
272 GALLBLADDER DISORDER 3 0.0002
273 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
274 ADRENAL INSUFFICIENCY 2 0.0002
275 MENISCUS INJURY 1 0.0002
276 CONJUNCTIVITIS 3 0.0002
277 INFUSION SITE EXTRAVASATION 1 0.0002
278 MIDDLE INSOMNIA 3 0.0002
279 SWOLLEN TONGUE 5 0.0002
280 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
281 PHOTOPHOBIA 3 0.0002
282 SCREAMING 1 0.0002
283 INFUSION SITE PAIN 2 0.0002
284 ANAPHYLACTIC SHOCK 4 0.0002
285 INCOHERENT 1 0.0002
286 EAR PAIN 3 0.0002
287 SOMNAMBULISM 1 0.0002
288 ASPERGILLUS INFECTION 1 0.0002
289 PULMONARY CONGESTION 2 0.0002
290 BLOOD PRESSURE ABNORMAL 3 0.0002
291 VIRAL INFECTION 5 0.0002
292 CHOLECYSTITIS CHRONIC 1 0.0001
293 POST-TRAUMATIC STRESS DISORDER 1 0.0001
294 EYE PRURITUS 5 0.0001
295 BRONCHITIS 11 0.0001
296 BRONCHIECTASIS 1 0.0001
297 SINUS CONGESTION 2 0.0001
298 ECCHYMOSIS 1 0.0001
299 RESPIRATION ABNORMAL 1 0.0001
300 FORMICATION 1 0.0001
301 DEVICE OCCLUSION 2 0.0001
302 THERMAL BURN 1 0.0001
303 SINUS TACHYCARDIA 2 0.0001
304 ORAL DISORDER 1 0.0001
305 NASAL CONGESTION 8 0.0001
306 SUNBURN 1 0.0001
307 PAROSMIA 1 0.0001
308 LACRIMATION INCREASED 4 0.0001
309 TENDON PAIN 1 0.0001
310 AORTIC ANEURYSM 1 0.0001
311 HAEMODYNAMIC INSTABILITY 1 0.0001
312 NEPHROLITHIASIS 6 0.0001
313 TINNITUS 6 0.0001
314 HIP ARTHROPLASTY 2 0.0001
315 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
316 RENAL FAILURE CHRONIC 1 0.0001
317 MUSCULOSKELETAL CHEST PAIN 2 0.0001
318 CONGENITAL ANOMALY 1 0.0001
319 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
320 DELUSION 2 0.0001
321 LUNG INFECTION 2 0.0001
322 AFFECTIVE DISORDER 1 0.0001
323 FURUNCLE 1 0.0001
324 BLOOD ALBUMIN DECREASED 1 0.0001
325 TRICUSPID VALVE INCOMPETENCE 1 0.0001
326 URTICARIA 21 0.0001
327 BLOOD PRESSURE FLUCTUATION 3 0.0001
328 BLOOD DISORDER 1 0.0001
329 SENSORY LOSS 1 0.0001
330 RHINORRHOEA 8 0.0001
331 MUSCLE DISORDER 1 0.0001
332 PRESYNCOPE 3 0.0001
333 POST PROCEDURAL INFECTION 1 0.0001
334 LUNG DISORDER 6 0.0001
335 SPINAL COMPRESSION FRACTURE 1 0.0001
336 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
337 ACUTE CORONARY SYNDROME 1 0.0001
338 BLOOD UREA INCREASED 2 0.0001
339 CANDIDA INFECTION 2 0.0001
340 PSEUDOMONAS INFECTION 1 0.0001
341 BLOOD MAGNESIUM DECREASED 1 0.0001
342 MUSCLE STRAIN 1 0.0001
343 SKIN SWELLING 1 0.0001
344 RESPIRATORY TRACT INFECTION 3 0.0001
345 URINE OUTPUT DECREASED 1 0.0001
346 GROIN PAIN 1 0.0001
347 LYMPHOCYTE COUNT DECREASED 2 0.0001
348 RESPIRATORY RATE INCREASED 1 0.0001
349 HAEMOLYTIC ANAEMIA 1 0.0001
350 MYOSITIS 1 0.0001
351 OROPHARYNGEAL DISCOMFORT 1 0.0001
352 COUGH 31 0.0001
353 DRUG EFFECT INCOMPLETE 4 0.0001
354 PNEUMONIA BACTERIAL 1 0.0001
355 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
356 PRODUCT DISTRIBUTION ISSUE 1 0.0001
357 PRODUCT DOSE OMISSION 7 0.0001
358 BACTERIAL INFECTION 2 0.0001
359 APPENDICITIS 1 0.0001
360 FOOT FRACTURE 2 0.0001
361 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
362 RECALLED PRODUCT ADMINISTERED 1 0.0001
363 PRODUCTIVE COUGH 5 0.0001
364 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
365 HERNIA 2 0.0001
366 PNEUMONIA 33 0.0001
367 HEPATOMEGALY 1 0.0001
368 BLADDER DISORDER 1 0.0001
369 SALIVARY HYPERSECRETION 1 0.0001
370 TOOTH ABSCESS 1 0.0001
371 NEUTROPHIL COUNT INCREASED 1 0.0001
372 INITIAL INSOMNIA 1 0.0001
373 PRODUCT PREPARATION ERROR 2 0.0001
374 OSTEOPOROSIS 4 0.0001
375 POOR VENOUS ACCESS 1 0.0001
376 PULMONARY HYPERTENSION 2 0.0001
377 TENDERNESS 1 0.0001
378 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
379 FOLLICULITIS 1 0.0001
380 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
381 INCONTINENCE 1 0.0001
382 RENAL PAIN 1 0.0001
383 MIGRAINE 9 0.0001
384 BIPOLAR DISORDER 1 0.0001
385 DYSPNOEA 52 0.0001
386 PULMONARY THROMBOSIS 1 0.0001
387 HYPERSENSITIVITY 17 0.0001
388 BLOOD PRESSURE INCREASED 14 0.0001
389 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
390 WOUND INFECTION 1 0.0001
391 TOOTH FRACTURE 1 0.0001
392 DENTAL CARIES 1 0.0001
393 LIP SWELLING 3 0.0001
394 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
395 INJECTION SITE PRURITUS 6 0.0001
396 RASH PAPULAR 2 0.0001
397 THROAT IRRITATION 4 0.0001
398 INTESTINAL PERFORATION 1 0.0001
399 BLOOD CALCIUM DECREASED 1 0.0001
400 MITRAL VALVE INCOMPETENCE 1 0.0001
401 MYOCARDIAL ISCHAEMIA 1 0.0001
402 MYOCARDITIS 1 0.0001
403 ELECTROLYTE IMBALANCE 1 0.0001
404 EYELID OEDEMA 1 0.0001
405 RASH MACULAR 3 0.0001
406 TREATMENT FAILURE 7 0.0001
407 ARRHYTHMIA 4 0.0001
408 ATAXIA 1 0.0001
409 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
410 HEPATITIS C 1 0.0001
411 FIBROMYALGIA 2 0.0001
412 INJECTION SITE URTICARIA 2 0.0001
413 PHARYNGITIS 1 0.0001
414 CYST 1 0.0001
415 TOOTH EXTRACTION 1 0.0001
416 DRY EYE 4 0.0001
417 SECRETION DISCHARGE 1 0.0001
418 CELLULITIS 4 0.0001
419 MYDRIASIS 1 0.0001
420 NODULE 1 0.0001
421 BEDRIDDEN 1 0.0001
422 BLOOD PRESSURE DECREASED 5 0.0001
423 EYE HAEMORRHAGE 1 0.0001
424 CARDIAC FAILURE CONGESTIVE 6 0.0001
425 MALIGNANT MELANOMA 1 0.0001
426 THROMBOSIS 6 0.0001
427 QUALITY OF LIFE DECREASED 1 0.0001
428 BLOOD BILIRUBIN INCREASED 2 0.0001
429 PRODUCT TASTE ABNORMAL 1 0.0001
430 LIMB INJURY 2 0.0001
431 DRUG TOXICITY 1 0.0001
432 IMPAIRED GASTRIC EMPTYING 1 0.0001
433 ACUTE HEPATIC FAILURE 1 0.0001
434 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
435 INFLUENZA 8 0.0001
436 DEMENTIA 2 0.0001
437 MASS 1 0.0001
438 CARPAL TUNNEL SYNDROME 1 0.0001
439 INTENTIONAL DOSE OMISSION 2 0.0001
440 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
441 HYPERSOMNIA 2 0.0001
442 CARDIOGENIC SHOCK 1 0.0001
443 LETHARGY 4 0.0001
444 PARAESTHESIA ORAL 1 0.0001
445 ANOSMIA 1 0.0001
446 INJECTION SITE HAEMATOMA 1 0.0001
447 LIVER FUNCTION TEST ABNORMAL 2 0.0001
448 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
449 DYSPHONIA 4 0.0001
450 ANGIOEDEMA 3 0.0001
451 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
452 COLITIS ULCERATIVE 3 0.0001
453 GASTROINTESTINAL DISORDER 6 0.0001
454 THERAPY NON-RESPONDER 3 0.0001
455 BLOOD POTASSIUM DECREASED 2 0.0001
456 HYPOAESTHESIA ORAL 1 0.0001
457 CORONARY ARTERY DISEASE 2 0.0001
458 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
459 DRUG ADMINISTRATION ERROR 2 0.0001
460 DEVICE RELATED INFECTION 1 0.0001
461 THYROID DISORDER 1 0.0001
462 LIMB DISCOMFORT 2 0.0001
463 ANKLE FRACTURE 1 0.0001
464 CYANOSIS 1 0.0001
465 PRODUCT USE COMPLAINT 1 0.0001
466 OCULAR HYPERAEMIA 3 0.0001
467 PULMONARY EMBOLISM 6 0.0001
468 PNEUMOTHORAX 1 0.0001
469 RESPIRATORY TRACT CONGESTION 1 0.0001
470 OBESITY 1 0.0001
471 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
472 SENSORY DISTURBANCE 1 0.0001
473 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
474 MUSCLE TIGHTNESS 1 0.0001
475 DEEP VEIN THROMBOSIS 4 0.0001
476 PRODUCT DOSE OMISSION ISSUE 18 0.0001
477 MULTIPLE FRACTURES 1 0.0001
478 EYE DISORDER 2 0.0001
479 COAGULOPATHY 1 0.0001
480 DEHYDRATION 8 0.0001
481 GAIT INABILITY 2 0.0001
482 CHILLS 7 0.0001
483 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
484 FLUSHING 6 0.0001
485 HEPATIC ENZYME INCREASED 4 0.0001
486 PRODUCT USE ISSUE 11 0.0001
487 PERIPHERAL SWELLING 9 0.0001
488 VISION BLURRED 8 0.0001
489 INFLAMMATION 3 0.0001
490 MUSCULOSKELETAL DISCOMFORT 1 0.0001
491 DEVICE DEFECTIVE 1 0.0001
492 LOCAL SWELLING 1 0.0001
493 SPEECH DISORDER 3 0.0001
494 PRURITUS 22 0.0001
495 EOSINOPHILIA 1 0.0001
496 DEPRESSED MOOD 3 0.0001
497 CONDITION AGGRAVATED 17 0.0001
498 GOUT 1 0.0001
499 GASTROENTERITIS VIRAL 1 0.0001
500 RASH PRURITIC 3 0.0001
501 OEDEMA 3 0.0001
502 LEUKOCYTOSIS 1 0.0001
503 TOOTHACHE 1 0.0001
504 OSTEOMYELITIS 1 0.0001
505 RESTLESS LEGS SYNDROME 1 0.0001
506 BONE DISORDER 1 0.0001
507 SUICIDAL IDEATION 5 0.0001
508 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
509 INJECTION SITE MASS 2 0.0001
510 CHEST PAIN 10 0.0001
511 OXYGEN SATURATION DECREASED 3 0.0001
512 HEPATIC CIRRHOSIS 1 0.0001
513 DYSPNOEA EXERTIONAL 2 0.0001
514 ARTHRALGIA 22 0.0001
515 URINARY TRACT INFECTION 9 0.0001
516 MALAISE 23 0.0001
517 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
518 EYE IRRITATION 3 0.0001
519 POST PROCEDURAL COMPLICATION 1 0.0001
520 DRUG PRESCRIBING ERROR 1 0.0001
521 NAUSEA 41 0.0001
522 ERUCTATION 1 0.0001
523 PRESCRIBED OVERDOSE 1 0.0001
524 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
525 SURGERY 3 0.0001
526 MENORRHAGIA 1 0.0001
527 ARTHRITIS 4 0.0001
528 DISABILITY 1 0.0001
529 SINUS DISORDER 1 0.0001
530 ABNORMAL BEHAVIOUR 2 0.0001
531 DISORIENTATION 2 0.0001
532 UPPER LIMB FRACTURE 1 0.0001
533 INJECTION SITE BRUISING 4 0.0001
534 JOINT SWELLING 6 0.0000
535 THERAPEUTIC RESPONSE DECREASED 3 0.0000
536 PRODUCT ADMINISTRATION ERROR 1 0.0000
537 ILL-DEFINED DISORDER 3 0.0000
538 BLINDNESS 2 0.0000
539 RIB FRACTURE 1 0.0000
540 INFLUENZA LIKE ILLNESS 4 0.0000
541 ABDOMINAL PAIN UPPER 10 0.0000
542 CARDIAC ARREST 4 0.0000
543 ROAD TRAFFIC ACCIDENT 2 0.0000
544 BACK PAIN 11 0.0000
545 RENAL FAILURE ACUTE 2 0.0000
546 RETCHING 1 0.0000
547 PRURITUS GENERALISED 1 0.0000
548 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
549 FAECES DISCOLOURED 1 0.0000
550 AMNESIA 3 0.0000
551 SWELLING FACE 3 0.0000
552 PRODUCT PRESCRIBING ISSUE 1 0.0000
553 INFUSION RELATED REACTION 3 0.0000
554 LIVER DISORDER 2 0.0000
555 STEVENS-JOHNSON SYNDROME 1 0.0000
556 TRANSAMINASES INCREASED 1 0.0000
557 RASH MACULO-PAPULAR 1 0.0000
558 HEPATOTOXICITY 1 0.0000
559 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
560 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
561 NO ADVERSE EVENT 8 0.0000
562 ERYTHEMA 9 0.0000
563 INJECTION SITE REACTION 3 0.0000
564 RASH 19 0.0000
565 SKIN DISCOLOURATION 2 0.0000
566 ADVERSE EVENT 4 0.0000
567 OFF LABEL USE 38 0.0000
568 MUSCLE TWITCHING 1 0.0000
569 PYREXIA 15 0.0000
570 PERICARDIAL EFFUSION 1 0.0000
571 PRODUCT PRESCRIBING ERROR 1 0.0000
572 RASH ERYTHEMATOUS 2 0.0000
573 MULTIPLE SCLEROSIS 2 0.0000
574 HEADACHE 26 0.0000
575 LOCALISED INFECTION 1 0.0000
576 NEURALGIA 1 0.0000
577 UNDERDOSE 3 0.0000
578 ATRIAL FIBRILLATION 4 0.0000
579 CEREBRAL INFARCTION 1 0.0000
580 LIVER INJURY 1 0.0000
581 ABASIA 1 0.0000
582 HEART RATE INCREASED 4 0.0000
583 INJECTION SITE ERYTHEMA 5 0.0000
584 EPISTAXIS 3 0.0000
585 AGEUSIA 1 0.0000
586 AGGRESSION 2 0.0000
587 HALLUCINATION 3 0.0000
588 UNEVALUABLE EVENT 3 0.0000
589 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
590 ABDOMINAL PAIN LOWER 1 0.0000
591 FLUID RETENTION 2 0.0000
592 LOSS OF CONSCIOUSNESS 5 0.0000
593 SKIN ULCER 1 0.0000
594 RASH GENERALISED 1 0.0000
595 FATIGUE 30 0.0000
596 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
597 DIPLOPIA 1 0.0000
598 VOMITING 18 0.0000
599 NERVOUSNESS 2 0.0000
600 MUSCULOSKELETAL PAIN 2 0.0000
601 APPLICATION SITE ERYTHEMA 1 0.0000
602 JOINT STIFFNESS 1 0.0000
603 GASTRITIS 1 0.0000
604 DERMATITIS ATOPIC 2 0.0000
605 INSOMNIA 10 0.0000
606 PLATELET COUNT DECREASED 4 0.0000
607 JAUNDICE 1 0.0000
608 PAIN OF SKIN 1 0.0000
609 DRUG EFFECT DECREASED 2 0.0000
610 CONFUSIONAL STATE 6 0.0000
611 DRY MOUTH 3 0.0000
612 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
613 PALLOR 1 0.0000
614 SKIN LESION 1 0.0000
615 DRUG INEFFECTIVE 48 0.0000
616 DRUG DOSE OMISSION 6 0.0000
617 ABNORMAL DREAMS 1 0.0000
618 DIVERTICULITIS 1 0.0000
619 FALL 12 0.0000
620 PROCEDURAL PAIN 1 0.0000
621 MENTAL STATUS CHANGES 1 0.0000
622 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
623 HAEMOPTYSIS 1 0.0000
624 NECK PAIN 2 0.0000
625 WOUND 1 0.0000
626 TARDIVE DYSKINESIA 1 0.0000
627 PAIN IN JAW 1 0.0000
628 MYALGIA 6 0.0000
629 FLATULENCE 2 0.0000
630 DEPRESSION 8 0.0000
631 ANXIETY 10 0.0000
632 INCORRECT DOSE ADMINISTERED 8 0.0000
633 RED BLOOD CELL COUNT DECREASED 1 0.0000
634 CONVULSION 2 0.0000
635 SOMNOLENCE 7 0.0000
636 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
637 PANCREATIC CARCINOMA 1 0.0000
638 INFECTION 5 0.0000
639 DYSSTASIA 1 0.0000
640 COVID-19 6 0.0000
641 PAIN 21 0.0000
642 PALPITATIONS 4 0.0000
643 BONE PAIN 2 0.0000
644 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
645 ACUTE MYOCARDIAL INFARCTION 1 0.0000
646 TACHYCARDIA 3 0.0000
647 CATARACT 2 0.0000
648 RESPIRATORY DISORDER 1 0.0000
649 FEELING ABNORMAL 8 0.0000
650 IRRITABILITY 2 0.0000
651 APHASIA 1 0.0000
652 VERTIGO 2 0.0000
653 DISCOMFORT 2 0.0000
654 FEELING HOT 2 0.0000
655 INJECTION SITE RASH 1 0.0000
656 HOSPITALISATION 5 0.0000
657 OROPHARYNGEAL PAIN 3 0.0000
658 VISUAL IMPAIRMENT 4 0.0000
659 BREAST CANCER 3 0.0000
660 DYSPHAGIA 3 0.0000
661 HEAD INJURY 1 0.0000
662 NEUROPATHY PERIPHERAL 3 0.0000
663 MOOD SWINGS 1 0.0000
664 METABOLIC ACIDOSIS 1 0.0000
665 WEIGHT INCREASED 7 0.0000
666 CONTUSION 3 0.0000
667 MOVEMENT DISORDER 1 0.0000
668 DRUG INTOLERANCE 3 0.0000
669 IMPAIRED HEALING 1 0.0000
670 OSTEONECROSIS 1 0.0000
671 STAPHYLOCOCCAL INFECTION 1 0.0000
672 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
673 DECREASED APPETITE 7 0.0000
674 TREMOR 5 0.0000
675 EXPIRED PRODUCT ADMINISTERED 1 0.0000
676 DIZZINESS 15 0.0000
677 SYNCOPE 3 0.0000
678 SKIN DISORDER 1 0.0000
679 DRY SKIN 4 0.0000
680 ABDOMINAL DISCOMFORT 5 0.0000
681 PRODUCT QUALITY ISSUE 4 0.0000
682 DIARRHOEA 19 0.0000
683 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
684 INJECTION SITE PAIN 9 0.0000
685 GASTRIC DISORDER 1 0.0000
686 MYOCARDIAL INFARCTION 5 0.0000
687 BURNING SENSATION 2 0.0000
688 HYPOXIA 1 0.0000
689 SLEEP DISORDER 2 0.0000
690 HYPERTENSION 6 0.0000
691 LYMPHADENOPATHY 1 0.0000
692 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
693 PRODUCT ADHESION ISSUE 1 0.0000
694 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
695 CRYING 1 0.0000
696 PANIC ATTACK 1 0.0000
697 RESPIRATORY FAILURE 2 0.0000
698 ACCIDENTAL OVERDOSE 1 0.0000
699 EYE SWELLING 1 0.0000
700 HOT FLUSH 2 0.0000
701 BLOOD GLUCOSE INCREASED 5 0.0000
702 INTESTINAL OBSTRUCTION 1 0.0000
703 MUSCULAR WEAKNESS 3 0.0000
704 COLITIS 1 0.0000
705 WEIGHT DECREASED 7 0.0000
706 ABORTION SPONTANEOUS 1 0.0000
707 CARDIAC FAILURE 2 0.0000
708 EXTRA DOSE ADMINISTERED 1 0.0000
709 OEDEMA PERIPHERAL 3 0.0000
710 DYSKINESIA 1 0.0000
711 NEUTROPHIL COUNT DECREASED 1 0.0000
712 POLLAKIURIA 1 0.0000
713 CARDIO-RESPIRATORY ARREST 1 0.0000
714 PAIN IN EXTREMITY 7 0.0000
715 CEREBROVASCULAR ACCIDENT 4 0.0000
716 RECTAL HAEMORRHAGE 1 0.0000
717 DEVICE DISLOCATION 1 0.0000
718 CONSTIPATION 5 0.0000
719 INTENTIONAL PRODUCT MISUSE 2 0.0000
720 RENAL FAILURE 3 0.0000
721 PULMONARY OEDEMA 1 0.0000
722 ADVERSE DRUG REACTION 2 0.0000
723 NEUTROPENIA 3 0.0000
724 SKIN IRRITATION 1 0.0000
725 BLOOD CHOLESTEROL INCREASED 1 0.0000
726 COGNITIVE DISORDER 1 0.0000
727 CARDIAC DISORDER 2 0.0000
728 SWELLING 2 0.0000
729 ASTHENIA 8 0.0000
730 DISEASE RECURRENCE 1 0.0000
731 ANAEMIA 4 0.0000
732 INTERSTITIAL LUNG DISEASE 1 0.0000
733 ALOPECIA 4 0.0000
734 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
735 THERAPY CESSATION 1 0.0000
736 HAEMOGLOBIN DECREASED 2 0.0000
737 ABDOMINAL DISTENSION 2 0.0000
738 ECZEMA 1 0.0000
739 PARAESTHESIA 3 0.0000
740 BRADYCARDIA 1 0.0000
741 TREATMENT NONCOMPLIANCE 1 0.0000
742 MEDICATION ERROR 1 0.0000
743 SEPSIS 2 0.0000
744 THROMBOCYTOPENIA 2 0.0000
745 BLISTER 1 0.0000
746 EYE PAIN 1 0.0000
747 HERPES ZOSTER 1 0.0000
748 PRODUCT SUBSTITUTION ISSUE 1 0.0000
749 SEIZURE 2 0.0000
750 ABDOMINAL PAIN 4 0.0000
751 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
752 STOMATITIS 1 0.0000
753 PLEURAL EFFUSION 1 0.0000
754 NASOPHARYNGITIS 3 0.0000
755 DEATH 14 0.0000
756 EXPOSURE DURING PREGNANCY 1 0.0000
757 HYPERHIDROSIS 2 0.0000
758 HYPOTENSION 3 0.0000
759 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
760 MEMORY IMPAIRMENT 2 0.0000
761 INJURY 1 0.0000
762 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
763 MOBILITY DECREASED 1 0.0000
764 OVERDOSE 3 0.0000
765 AGITATION 1 0.0000
766 DYSGEUSIA 1 0.0000
767 HYPOAESTHESIA 2 0.0000
768 ACNE 1 0.0000
769 CHRONIC KIDNEY DISEASE 1 0.0000
770 DIABETES MELLITUS 1 0.0000
771 INJECTION SITE SWELLING 1 0.0000
772 DRUG INTERACTION 2 0.0000
773 COMPLETED SUICIDE 1 0.0000
774 SKIN EXFOLIATION 1 0.0000
775 PRODUCT STORAGE ERROR 1 0.0000
776 DRUG WITHDRAWAL SYNDROME 1 0.0000
777 DEVICE ISSUE 1 0.0000
778 DYSPEPSIA 1 0.0000
779 ILLNESS 1 0.0000
780 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
781 HAEMORRHAGE 1 0.0000
782 RHEUMATOID ARTHRITIS 1 0.0000
783 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
784 DISEASE PROGRESSION 1 0.0000
785 EMOTIONAL DISTRESS 1 0.0000
786 PSORIASIS 1 0.0000
787 ACUTE KIDNEY INJURY 1 0.0000
788 MUSCLE SPASMS 1 0.0000